Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Valeo Pharma In-Play, New HesperCo™ Immune System Support Scientifically Demonstrated

Shares of Valeo Pharma Inc. (CSE: VPH) (Frankfurt: VP2) poised for substantial upside revaluation to reflect the major ‘company –maker’ potential in HesperCo™ as the market figures out it is set to be the subject of Covid-19 clinical trial. Valeo will benefit...

Confessions of a gold analyst: "It's all my fault"

Common sense dictates that when you need information or advice on something you're unfamiliar with, you consult with a professional. That's what people do, whether refinancing a home, choosing an insurance product, or fixing a broken heater. While professionals certainly hav...

X-Terra Resources: The Undiscovered Discovery

Investor Riley Ireland provides his investment thesis for this explorer with gold properties in Canada. X-Terra's Grog Property Investment Highlights: Strong management with direct ownership Low market cap of $4,709,629 New gold di...

A ‘Novel’ Investment In Psychedelic-Inspired Medicines

Stockhouse investors are keenly aware of the booming trend in the psychedelic healthcare space…in many ways the new Cannabis 2.0 over the last 12 – 24 months. Capital markets have taken to them en masse – a market now estimated to be in excess of USD$5 billion and expected ...

Buzz on the Bullboards: Don’t Get Spooked by these Market Performers

There is nothing scarier on Hallowe’en than an uncertain stock market. Lately, this is exactly what investors have been dealing with and part of what we try to demystify at Stockhouse. There have been many companies moving independent of the market...

Rising US Dollar Mutes Metals Moves and Puts Pressures on Global Markets

The Rising US Dollar continues to shift the investing landscape as a stronger US Dollar mutes the price acceleration in precious metals and continue to put pricing pressures on the global economy. The current levels of the US Dollar Index, above 99, clearly illustrates how the...

The Next Takeout Targets in Gold

There have been close to $6 billion in gold buyouts the last 2 weeks. Coming into tax loss season, it’s time to sharpen your pencils and get your cash ready for opportunities on the horizon. The deals that happened over the last 2 weeks should not co...

Doctor Copper Strikes – A True Economic Barometer

Copper has long been an excellent proxy for global economic health. It’s used in everything from washing machines to electric cars. That’s why copper is often referred to as “Doctor Copper” – because it c...

Top 5 Gold Miner Intercepts for February – Wesdome, Blackham, K92, Walker River and Gran Colombia

Gold exploration is challenging and complex. It requires significant time, financial resources and expertise in many disciplines such as geography, geology, chemistry, and engineering. The likelihood of a discovery leading to a mine being developed is very low – less than 0....

Atomera: When Will Revenues Start?

Atomera Inc. (ATOM:NASDAQ) reported earnings on Wednesday after the close. The numbers are rather meaningless for Atomera as they are pre-revenue. What investors are looking for is clues to when revenues will start and the likelihood that customers will adopt Atomera's...
1 2 3 4